Search - tctmd.com

Displaying 1 - 20 of 53

Sort: Relevancy | Date

Presentation TCT 2025

TCT 1007: Short Vs. Long Dual Antiplatelet Therapy for Chronic Total Occlusions Coronary Interventions: A systematic Review and Bayesian Meta-Analysis

Presenter: Ricardo Fonseca Oliveira Suruagy-Motta

October 27, 2025

Presentation TCT 2025

TCT 380: Comparative Effectiveness of Stenting Strategies for Left Main Bifurcation Disease: A Bayesian Network Meta-Analysis with Reconstructed Survival Curves

Presenter: Maryam Asif

October 26, 2025

Presentation TCT 2025

TCT 750: Guideline-Directed Medical Therapy for Heart Failure after Transcatheter Edge-to-Edge Mitral Valve Repair – A Frequentist and Bayesian Meta-Analysis

Presenter: Jesslyn Natalie Hariyanto

October 25, 2025

Elderly CABG Patients Stand to Benefit From Artery-Only Strategy

News Daily News

Elderly CABG Patients Stand to Benefit From Artery-Only Strategy

October 13, 2025

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

News Daily News

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

Michael O'Riordan

March 26, 2025

Immediate Angiography in OHCA Without STEMI Could Harm: TOMAHAWK and COACT

News Daily News

Immediate Angiography in OHCA Without STEMI Could Harm: TOMAHAWK and COACT

December 27, 2024

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

News Conference News TCT 2024

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

October 30, 2024

‘Disproportionate’ Suicide/Self-Harm Signal With Semaglutide: WHO Database

News Daily News

‘Disproportionate’ Suicide/Self-Harm Signal With Semaglutide: WHO Database

Michael O'Riordan

August 21, 2024

Thrombectomy Advantage for Large-Core Strokes Widens Over 12 Months: TESLA

News Conference News ISC 2024

Thrombectomy Advantage for Large-Core Strokes Widens Over 12 Months: TESLA

February 09, 2024

BIOSTEMI: Degradable-Polymer, Ultrathin-Strut DES Shows No Late Catch-up at 5 Years

News Conference News TCT 2023

BIOSTEMI: Degradable-Polymer, Ultrathin-Strut DES Shows No Late Catch-up at 5 Years

October 27, 2023

ADVENT: Pulsed-Field Ablation for Paroxysmal AF Performs Well vs Thermal Systems

News Conference News ESC 2023

ADVENT: Pulsed-Field Ablation for Paroxysmal AF Performs Well vs Thermal Systems

August 27, 2023

Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel

News Daily News

Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel

August 23, 2023

TESLA Falls Short, but Experts Still See Role for EVT in Large-Core Strokes

News Conference News ESOC 2023

TESLA Falls Short, but Experts Still See Role for EVT in Large-Core Strokes

May 31, 2023

Meta-analysis Finds No Excess Mortality Risk With Coronary Revascularization

News Conference News EuroPCR 2023

Meta-analysis Finds No Excess Mortality Risk With Coronary Revascularization

Michael O'Riordan

May 19, 2023

PROMISE II: Flow-Diverting Procedure May Save Limbs in CLTI

News Daily News

PROMISE II: Flow-Diverting Procedure May Save Limbs in CLTI

March 29, 2023

Conversations in Cardiology: ISCHEMIA’s Lasting Fallout

News Opinion Conversations in Cardiology

Conversations in Cardiology: ISCHEMIA’s Lasting Fallout

December 29, 2022

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

News Conference News AHA 2022

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

November 09, 2022

ISCHEMIA-EXTEND: So Far, Deaths Match for Invasive and Conservative Arms in Stable CAD

News Conference News AHA 2022

ISCHEMIA-EXTEND: So Far, Deaths Match for Invasive and Conservative Arms in Stable CAD

November 06, 2022

More Endpoints, More Problems: FDA Offers Advice for Multi-endpoint Trials

News Daily News

More Endpoints, More Problems: FDA Offers Advice for Multi-endpoint Trials

Michael O'Riordan

October 28, 2022

Hospital Culture, Physician Preference Mostly Drive IVUS/OCT in PCI

News Daily News

Hospital Culture, Physician Preference Mostly Drive IVUS/OCT in PCI

October 24, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.